Cost-effectiveness of sevelamer in the treatment of hyperphosphatemia associated with chronic kidney disease in Mexico

被引：0
|
作者：
Idrovo, J. [1 ]
Rivas, R. [1 ]
Zapata, L. [1 ]
机构：
[1] Guia Mark, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70949-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A301 / A301
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF SEVELAMER IN THE TREATMENT OF HYPERPHOSPHATEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE IN ARGENTINA
    Rivas, R.
    Idrovo, J.
    Zapata, L.
    VALUE IN HEALTH, 2010, 13 (03) : A210 - A210
  • [2] THE COST-EFFECTIVENESS OF PHOSPHATE BINDERS FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE (CKD)
    Keith, M. S.
    Carlton, R.
    Meissner, B. L.
    VALUE IN HEALTH, 2009, 12 (07) : A309 - A309
  • [3] A COST-EFFECTIVENESS MODEL OF PHOSPHATE BINDERS FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE (CKD)
    Keith, Michael
    Smyth, Michael
    Carlton, Rashad
    Meissner, Brian
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : A69 - A69
  • [4] COST-EFFECTIVENESS ANALYSIS OF SUCROFERRIC OXYHYDROXIDE IN TREATMENT OF HYPERPHOSPHATEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Ugrekhelidze, D.
    Yagudina, R.
    Kulikov, A.
    VALUE IN HEALTH, 2016, 19 (07) : A518 - A518
  • [5] Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease
    Habbous, Steven
    Przech, Sebastian
    Martin, Janet
    Garg, Amit X.
    Sarma, Sisira
    VALUE IN HEALTH, 2018, 21 (03) : 318 - 325
  • [6] Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Chronic Kidney Disease Before and During Dialysis
    Vegter, Stefan
    Tolley, Keith
    Keith, Michael S.
    Postma, Maarten J.
    VALUE IN HEALTH, 2011, 14 (06) : 852 - 858
  • [7] COST-EFFECTIVENESS ANALYSIS OF TREATMENTS IN CHRONIC KIDNEY DISEASE IN MEXICO
    Frias Gasga, A. E.
    Cortes-Sanabria, L.
    Rueda Galicia, C.
    Soto, H.
    Guzman Vazquez, S.
    VALUE IN HEALTH, 2022, 25 (07) : S393 - S394
  • [8] CHALLENGES IN ASSESSING COST-EFFECTIVENESS OF THERAPIES FOR DIALYSIS PATIENTS: A CASE STUDY OF SEVELAMER FOR THE TREATMENT OF HYPERPHOSPHATEMIA
    Grima, D.
    Mendelssohn, D.
    Airia, P.
    Dunn, E.
    Bernard, L.
    VALUE IN HEALTH, 2010, 13 (03) : A78 - A78
  • [9] The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease
    Yarnoff, Benjamin O.
    Hoerger, Thomas J.
    Simpson, Siobhan A.
    Pavkov, Meda E.
    Burrows, Nilka R.
    Shrestha, Sundar S.
    Williams, Desmond E.
    Zhuo, Xiaohui
    PLOS ONE, 2016, 11 (07):
  • [10] COST EFFECTIVENESS EVALUATION OF DAPAGLIFLOZIN IN THE TREATMENT OF CHRONIC KIDNEY DISEASE IN MEXICO
    Buritica, M. P.
    Diaz, O.
    Rubio Ponce, R.
    VALUE IN HEALTH, 2022, 25 (12) : S128 - S128
12345